Macrophages and microglia are the central cells in the development of HIV dementia (HIVD): macrophages may be responsible for transporting virus into the central nervous system (CNS), and they and microglia are the major cell type harboring HIV sequences. Macrophages and microglia may be responsible for the production of neurotoxins and potentially toxic viral gene products like gp12O and tat, and if neuroglia and neurons are infected to any great extent, microglia are undoubtedly the source of virus. One aspect of neurotropism, the ability to preferentially replicate in microglia, has been identified by studying a large panel of isolates obtained at the time of primary HIV infection. With these, as well as viruses isolated from the brains of individuals with HIVD, we propose to study the microglial-virus interactions important in the development of HIVD in three specific aims. In the first aim we will (i) determine the mechanism of accelerated microglial replication using PCR to delineate the sequential steps of the infectious process and (ii) define whether microglial-tropism is determined at the level of cell entry (iii) determine why microglia are inherently more susceptible than MDM to HIV infection and (iv) explore the effects of the state of activation of microglia, and the influence of cytokines present in brain, like tumor necrosis factor alpha (TNFalpha) and interleukin 1 beta (IL1beta) on viral replication. These experiments will test the hypothesis that microglial tropism is a phenomenon whose mechanism can be clearly defined by analyzing the series of steps involved in viral replication. In the second aim we will define the genetic underpinnings of preferential replication in microglia, and in the third aim we will determine whether neurovirulence is strictly correlated with increased replication by studying the effects of viral infection with primary isolates from blood and brain on microglial secretion of potential neurotoxins like TNFalpha and platelet activating factor (PAF). However, since the critical neurotoxins may not yet have been identified by previous strategies, we will also use differential display, a technique that may detect mRNAs that are either increased or decreased in infected microglia, and has the advantage that it will provide an unbiased look at the system. The results of these studies should help delineate the rational treatment of HIVD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS035743-03
Application #
2839404
Study Section
AIDS and Related Research Study Section 7 (ARRG)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1996-12-01
Project End
1999-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ryzhova, Elena V; Vos, Robin M; Albright, Andrew V et al. (2006) Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages. J Virol 80:2694-704
Martin-Garcia, Julio; Cocklin, Simon; Chaiken, Irwin M et al. (2005) Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate. J Virol 79:6703-13
Albright, Andrew V; Vos, Robin M; Gonzalez-Scarano, Francisco (2004) Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55(Gag). Virology 325:328-39
Ryzhova, Elena V; Crino, Peter; Shawver, Linda et al. (2002) Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples. Virology 297:57-67
Ryzhova, Elena; Whitbeck, J Charles; Canziani, Gabriela et al. (2002) Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4. J Virol 76:7903-9
Albright, A V; Martin, J; O'Connor, M et al. (2001) Interactions between HIV-1 gp120, chemokines, and cultured adult microglial cells. J Neurovirol 7:196-207
Shieh, J T; Martin, J; Baltuch, G et al. (2000) Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. J Virol 74:693-701
Albright, A V; Erickson-Viitanen, S; O'Connor, M et al. (2000) Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro. AIDS Res Hum Retroviruses 16:1527-37
Albright, A V; Shieh, J T; O'Connor, M J et al. (2000) Characterization of cultured microglia that can be infected by HIV-1. J Neurovirol 6 Suppl 1:S53-60
Albright, A V; Shieh, J T; Itoh, T et al. (1999) Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73:205-13

Showing the most recent 10 out of 13 publications